Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Short term Debt (2022 - 2023)

Historic Short term Debt for bioAffinity Technologies (BIAF) over the last 2 years, with Q2 2023 value amounting to $42334.0.

  • bioAffinity Technologies' Short term Debt changed N/A to $42334.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $42334.0, marking a year-over-year change of. This contributed to the annual value of $251746.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that bioAffinity Technologies reported Short term Debt of $42334.0 as of Q2 2023.
  • bioAffinity Technologies' 5-year Short term Debt high stood at $500000.0 for Q3 2022, and its period low was $42334.0 during Q2 2023.